Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Becher

Showing results (21-30 of 280) with videos related to

Pageof 28
Sort By:
European Journal of Immunology|June 23, 2009
IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivoGabor Gyülvészi, Stefan Haak, Burkhard Becher
Expert Opinion on Therapeutic Targets|November 23, 2005
IL-23: changing the verdict on IL-12 function in inflammation and autoimmunityKatharina Kreymborg, Ulrike Böhlmann, Burkhard Becher
Current Opinion in Neurology|May 6, 2010
Cytokine networks in multiple sclerosis: lost in translationLaura Codarri, Adriano Fontana, Burkhard Becher
Immunotherapy|July 20, 2010
Th17 cells in autoimmune disease: changing the verdictStefan Haak, Gabor Gyülveszi, Burkhard Becher
Immunity|November 17, 2016
GM-CSF: From Growth Factor to Central Mediator of Tissue InflammationBurkhard Becher, Sonia Tugues, Melanie Greter
The Journal of Experimental Medicine|November 16, 2019
Targeting interleukin-17 in chronic inflammatory disease: A clinical perspectivePascale Zwicky, Susanne Unger, Burkhard Becher
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2006
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brainBurkhard Becher, Ingo Bechmann, Melanie Greter
Seminars in Immunology|November 12, 2021
GM-CSF: Master regulator of the T cell-phagocyte interface during inflammationFlorian Ingelfinger, Donatella De Feo, Burkhard Becher
European Journal of Immunology|September 6, 2012
IL-23: one cytokine in control of autoimmunityAndrew L Croxford, Florian Mair, Burkhard Becher
Trends in Immunology|October 4, 2015
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue DamageAndrew L Croxford, Sabine Spath, Burkhard Becher
Pageof 28

Showing results (21-30 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Immunology|June 23, 2009
IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivoGabor Gyülvészi, Stefan Haak, Burkhard Becher
Expert Opinion on Therapeutic Targets|November 23, 2005
IL-23: changing the verdict on IL-12 function in inflammation and autoimmunityKatharina Kreymborg, Ulrike Böhlmann, Burkhard Becher
Current Opinion in Neurology|May 6, 2010
Cytokine networks in multiple sclerosis: lost in translationLaura Codarri, Adriano Fontana, Burkhard Becher
Immunotherapy|July 20, 2010
Th17 cells in autoimmune disease: changing the verdictStefan Haak, Gabor Gyülveszi, Burkhard Becher
Immunity|November 17, 2016
GM-CSF: From Growth Factor to Central Mediator of Tissue InflammationBurkhard Becher, Sonia Tugues, Melanie Greter
The Journal of Experimental Medicine|November 16, 2019
Targeting interleukin-17 in chronic inflammatory disease: A clinical perspectivePascale Zwicky, Susanne Unger, Burkhard Becher
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2006
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brainBurkhard Becher, Ingo Bechmann, Melanie Greter
Seminars in Immunology|November 12, 2021
GM-CSF: Master regulator of the T cell-phagocyte interface during inflammationFlorian Ingelfinger, Donatella De Feo, Burkhard Becher
European Journal of Immunology|September 6, 2012
IL-23: one cytokine in control of autoimmunityAndrew L Croxford, Florian Mair, Burkhard Becher
Trends in Immunology|October 4, 2015
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue DamageAndrew L Croxford, Sabine Spath, Burkhard Becher
Pageof 28